.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Argus Health
QuintilesIMS
Fuji
McKesson
Cerilliant
Dow
Express Scripts
US Army
Novartis

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019855

« Back to Dashboard
NDA 019855 describes ELIMITE, which is a drug marketed by Mylan Pharms Inc and is included in one NDA. It is available from two suppliers. Additional details are available on the ELIMITE profile page.

The generic ingredient in ELIMITE is permethrin. There are five drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the permethrin profile page.

Summary for 019855

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details

Pharmacology for NDA: 019855

Ingredient-typePyrethrins

Medical Subject Heading (MeSH) Categories for 019855

Suppliers and Packaging for NDA: 019855

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ELIMITE
permethrin
CREAM;TOPICAL 019855 NDA Prestium Pharma, Inc. 40076-230 40076-230-60 1 TUBE in 1 CARTON (40076-230-60) > 60 g in 1 TUBE
ELIMITE
permethrin
CREAM;TOPICAL 019855 NDA AUTHORIZED GENERIC Renaissance Pharma, Inc. 40085-615 40085-615-60 1 TUBE in 1 CARTON (40085-615-60) > 60 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength5%
Approval Date:Aug 25, 1989TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Johnson and Johnson
Baxter
Accenture
Healthtrust
McKesson
Cipla
Mallinckrodt
US Department of Justice
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot